These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 31218232
1. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy. Wang J, Wang G, Liang Y, Zhou X. J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232 [Abstract] [Full Text] [Related]
2. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Regmi A, Liu G, Zhong X, Hu S, Ma R, Gou L, Zafar MI, Chen L. Med Sci Monit; 2019 Mar 05; 25():1699-1708. PubMed ID: 30835718 [Abstract] [Full Text] [Related]
3. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R. PLoS One; 2016 Mar 05; 11(3):e0150154. PubMed ID: 26930277 [Abstract] [Full Text] [Related]
4. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan. Chien HY, Chen CY, Chiu YH, Lin YC, Li WC. Int J Med Sci; 2016 Mar 05; 13(6):457-65. PubMed ID: 27279796 [Abstract] [Full Text] [Related]
5. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy. Li W, Yang S, Qiao R, Zhang J. Clin Lab; 2018 May 01; 64(5):709-718. PubMed ID: 29739042 [Abstract] [Full Text] [Related]
6. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy. Akhbari M, Khalili M, Shahrabi-Farahani M, Biglari A, Bandarian F. Clin Lab; 2019 Aug 01; 65(8):. PubMed ID: 31414764 [Abstract] [Full Text] [Related]
7. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis. Eissa S, Matboli M, Bekhet MM. Biomed Pharmacother; 2016 Oct 01; 83():92-99. PubMed ID: 27470555 [Abstract] [Full Text] [Related]
8. Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes. Roux M, Perret C, Feigerlova E, Mohand Oumoussa B, Saulnier PJ, Proust C, Trégouët DA, Hadjadj S. Nephrol Dial Transplant; 2018 Dec 01; 33(12):2201-2207. PubMed ID: 29361146 [Abstract] [Full Text] [Related]
9. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy. Akpınar K, Aslan D, Fenkçi SM, Caner V. Diagnosis (Berl); 2022 Nov 01; 9(4):499-507. PubMed ID: 35976169 [Abstract] [Full Text] [Related]
10. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy. Kim H, Bae YU, Jeon JS, Noh H, Park HK, Byun DW, Han DC, Ryu S, Kwon SH. J Transl Med; 2019 Jul 22; 17(1):236. PubMed ID: 31331349 [Abstract] [Full Text] [Related]
11. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X. World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818 [Abstract] [Full Text] [Related]
12. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis. Wang L, Lin J, Yu T, Zuo Q, Shen B, Zhang H, Liu B, Cai D, Mao H, Zhao H, Zou Q, Xiao B. Clin Biochem; 2020 Oct 07; 84():79-86. PubMed ID: 32673627 [Abstract] [Full Text] [Related]
13. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study. Liu Q, Wang M, Xu T, Liang W, Yang F. J Clin Lab Anal; 2022 Feb 07; 36(2):e24210. PubMed ID: 34964177 [Abstract] [Full Text] [Related]
14. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1. Tang WB, Zheng L, Yan R, Yang J, Ning J, Peng L, Zhou Q, Chen L. Nephron; 2018 Feb 07; 138(3):231-242. PubMed ID: 29227974 [Abstract] [Full Text] [Related]
15. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy. Han Q, Zhang Y, Jiao T, Li Q, Ding X, Zhang D, Cai G, Zhu H. Nutr Diabetes; 2021 Jun 30; 11(1):24. PubMed ID: 34193814 [Abstract] [Full Text] [Related]
16. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy. Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY. Diabetes Metab Res Rev; 2015 Oct 30; 31(7):717-24. PubMed ID: 25952368 [Abstract] [Full Text] [Related]
17. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Al-Kafaji G, Al-Muhtaresh HA. Mol Med Rep; 2018 Jul 30; 18(1):1171-1180. PubMed ID: 29845236 [Abstract] [Full Text] [Related]
18. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy. Jia Y, Guan M, Zheng Z, Zhang Q, Tang C, Xu W, Xiao Z, Wang L, Xue Y. J Diabetes Res; 2016 Jul 30; 2016():7932765. PubMed ID: 26942205 [Abstract] [Full Text] [Related]
19. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Lung Cancer; 2013 Sep 30; 81(3):388-396. PubMed ID: 23756108 [Abstract] [Full Text] [Related]
20. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy. Hong Y, Wang J, Zhang L, Sun W, Xu X, Zhang K. Ann Clin Biochem; 2021 Mar 30; 58(2):141-148. PubMed ID: 33302703 [Abstract] [Full Text] [Related] Page: [Next] [New Search]